CAVALRY_37748
Posted - 5 hours ago
$RGLS How and why are analysts calling this for 10.00??
lizquita
Posted - 2 days ago
$RGLS when is this going to wake up????
MattyDee
Posted - 5 days ago
$RGLS up day on Monday 🐂🐂🐂
Ataifanboymentalhealthz
Posted - 6 days ago
$RNAZ because microrna biotechs not much success in many areas. Had one company forgot name that merged with TED company after failure in PTOC. Also look at $RGLS they have decent chance for current indication but at point going for hep c and hep b
Zainginegeiol
Posted - 1 week ago
$RGLS $ORMP 🚨💥🚀🔥 PR is incoming. $BOLT.CN $.31 (+19.23%) average volume increased ~100%. I'm going to add on Monday if it's still this low. Latest News 🚀🤑 Market cap at $5.7M; Whiting’s influence may drive upward movement if new partnerships or exploration progress 1️⃣ Bolt Metals ($BOLT.CN) advances with two key updates: Ben Whiting joins as Technical Advisor, and a C$544,500 private placement closed 💸. 2️⃣ Funding: The placement includes shares and warrants, exercisable at C$0.75 for two years, with proceeds for exploration, working capital, and copper project growth ⚒️
Kobe2324
Posted - 1 week ago
$RGLS Jay hagan is a pretty big loser and a puppet
DonCorleone77
Posted - 1 week ago
$RGLS Regulus reports Q3 EPS (21c), consensus (17c) As of September 30, 2024, Regulus had $87.3M in cash, cash equivalents and short-term investments. "We have remained focused on rapidly progressing RGLS8429 for the potential treatment of ADPKD and were pleased to announce the completion of enrollment in our fourth and final cohort of the Phase 1b MAD study last month. Our team continues to be energized not only by the positive results we've seen so far in the clinic but also by the recent opportunities we've had to interact with the broader nephrology community and present on RGLS8429 at recent meetings," said Jay Hagan, CEO. "We are in a strong position as we move towards the end of the year and into 2025. We expect to share preliminary topline data from a substantial number of patients from the fourth cohort in the Phase 1b MAD study of RGLS8429 in ADPKD in early 2025."
BioTechChap
Posted - 10/30/24
$RGLS What's going on with the pre-market activity? FDA interaction outcome leaked?
havy1369
Posted - 10/30/24
$RGLS anything under $1.71 is a steal
incom101
Posted - 10/29/24
$RGLS $VTYX that's what got me to DD it.
incom101
Posted - 10/29/24
$RGLS Grabbed a starter here. Good afternoon all
gestion
Posted - 10/29/24
$RGLS Today the run up begins to two major catalysts. (1) the end of year meeting with FDA to determine the design and fast track designation for potential pivotal phase 2 and (2) the Q1 readout for cohort 4 data
Estimize
Posted - 10/28/24
Wall St is expecting 57.67% YoY EPS growth for $RGLS in Q3, up from 54.05% in Q2 [Reporting 11/07 AMC]
http://www.estimize.com/intro/rgls?c
themacromindset
Posted - 1 month ago
$RGLS
- Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) RGLS-8429 Trial
Thestocktraderhubzee
Posted - 1 month ago
$RGLS Regulus Therapeutics Completes Enrollment Of Fourth Cohort In Phase 1b Multiple-Ascending Dose Clinical Trial Of RGLS8429 For Treatment Of Autosomal Dominant Polycystic Kidney Disease With 26 Patients Enrolled
gestion
Posted - 1 month ago
$RGLS Company will have its meeting with the FDA anytime and we will get the minutes & results within 1 month. I anticipate the stock will start moving out of this range soon as we approach this important catalyst. The company has been quiet since June 24th cohort 3 data. If they get the greenlight to phase 2 with a favorable study design, should be very good news
Biotechs5454
Posted - 1 month ago
$RGLS Here we go again? No idea of all this means anything but it has been out of character the last few weeks.
Steve_382
Posted - 1 month ago
@NetNinja And over a million shares also. $RGLS Odd.
NetNinja
Posted - 1 month ago
$RGLS Another odd move up out of nowhere.
Biotechs5454
Posted - 1 month ago
$RGLS Where is my hopium.
